Abbott Laboratories (ABT) vs Boston Scientific Corporation (BSX)
Abbott Laboratories and Boston Scientific Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $174.8B against $64.7B — 2.7× the size. Boston Scientific Corporation trades at the lower P/E: 17.7× against 32.8×. Boston Scientific Corporation grew revenue faster over the last twelve months: 13.5% against 8.06%. Boston Scientific Corporation has the higher net margin (17.5% vs 11.7%) and the higher return on invested capital (6.96% vs 5.83%). Across the 22 metrics below, Boston Scientific Corporation leads on 19 and Abbott Laboratories on 3.
Valuation
Profitability
| Metric | ABT | BSX | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 69.92% | 56.01% |
| Operating margin | 15.77% | 19.76% | (15.03%) |
| Net margin | 11.65% | 17.50% | (20.40%) |
| Free cash flow margin | 16.80% | 17.27% | (7.24%) |
| Return on equity | 10.58% | 15.37% | (15.32%) |
| Return on assets | 5.62% | 8.47% | (19.72%) |
| Return on invested capital | 5.83% | 6.96% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack